NASDAQ : KNSA

Kiniksa Pharmaceuticals International, plc — Key statistics

Healthcare · Drug Manufacturers - Specialty & Generic · United Kingdom

Last price 97.56 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 7.67B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Key statistics

Valuation

Measure	Value
Market Cap	7.25B
Enterprise Value	6.69B

Dates

Measure	Value
Earnings Date	Oct 27, 2026
Ex-Dividend Date	n/a

Shares

Measure	Value
Current Share Class	48.84M
Shares Outstanding	78.57M
Shares Change (YoY)	+8.67%
Shares Change (QoQ)	+1.82%
Owned by Insiders (%)	4.32%
Owned by Institutions (%)	56.49%
Float	40.41M

Ratios

Measure	Value
PE Ratio	69.68
Forward PE	48.48
PS Ratio	7.66
Forward PS	5.68
PB Ratio	10.19
P/TBV Ratio	10.42
P/FCF Ratio	36.75
P/OCF Ratio	36.45
PEG Ratio	1.05

Evratios

Measure	Value
EV / Earnings	61.03
EV / Sales	7.07
EV / EBITDA	50.52
EV / EBIT	51.25
EV / FCF	33.91

Financialposition

Measure	Value
Current Ratio	3.91
Quick Ratio	3.12
Debt / Equity	0.01
Debt / EBITDA	0.06
Debt / FCF	0.04
Interest Coverage	n/a

Financialefficiency

Measure	Value
Return on Equity (ROE)	17.59%
Return on Assets (ROA)	9.62%
Return on Invested Capital (ROIC)	68.29%
Return on Capital Employed (ROCE)	16.49%
Weighted Average Cost of Capital (WACC)	4.44%
Revenue Per Employee	$2.58M
Profits Per Employee	$299,366
Employee Count	366
Asset Turnover	1.12
Inventory Turnover	5.79

Taxes

Measure	Value
Income Tax	36.58M
Effective Tax Rate	25.03%

Stockprice

Measure	Value
Beta (5Y)	0.04
52-Week Price Change	+146.76%
50-Day Moving Average	79.16
200-Day Moving Average	60.21
Relative Strength Index (RSI)	62.98
Average Volume (20 Days)	867,150

Shortselling

Measure	Value
Short Interest	3.76M
Short Previous Month	3.78M
Short % of Shares Out	4.79%
Short % of Float	9.31%
Short Ratio (days to cover)	6.53

Incomestatement

Measure	Value
Revenue	945.96M
Gross Profit	513.39M
Operating Income	130.47M
Pretax Income	146.15M
Net Income	109.57M
EBITDA	132.36M
EBIT	130.47M
Earnings Per Share (EPS)	$1.32

Balancesheet

Measure	Value
Cash & Cash Equivalents	568.76M
Total Debt	7.88M
Net Cash	560.87M
Net Cash Per Share	$7.14
Equity (Book Value)	710.19M
Book Value Per Share	9.05
Working Capital	558.24M

Cashflow

Measure	Value
Operating Cash Flow	198.84M
Capital Expenditures	-1.64M
Depreciation & Amortization	1.90M
Net Borrowing	n/a
Free Cash Flow	197.20M
FCF Per Share	$2.51

Margins

Measure	Value
Gross Margin	54.27%
Operating Margin	13.79%
Pretax Margin	15.45%
Profit Margin	11.58%
EBITDA Margin	13.99%
EBIT Margin	13.79%
FCF Margin	20.85%

Dividends

Measure	Value
Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
FCF Payout Ratio	n/a
Buyback Yield	-8.67%
Shareholder Yield	-8.67%
Earnings Yield	1.44%
FCF Yield	2.72%

Analystforecasts

Measure	Value
Price Target	$109.43
Price Target Difference	18.64%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (3Y)	30.40%
EPS Growth Forecast (3Y)	52.21%

Stocksplits

Measure	Value
Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Measure	Value
Altman Z-Score	10.42
Piotroski F-Score	7

Fairvalue

Measure	Value
Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside